GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹11,813 Cr | ₹11,583 Cr | ₹12,305 Cr | ₹10,944 Cr | ₹10,641 Cr |
What is the latest Revenue of GLENMARK PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹11,813 Cr |
| Mar2024 | ₹11,583 Cr |
| Mar2023 | ₹12,305 Cr |
| Mar2022 | ₹10,944 Cr |
| Mar2021 | ₹10,641 Cr |
How is Revenue of GLENMARK PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹11,813 Cr | 1.98 | |
| Mar2024 | ₹11,583 Cr | -5.86 | |
| Mar2023 | ₹12,305 Cr | 12.44 | |
| Mar2022 | ₹10,944 Cr | 2.85 | |
| Mar2021 | ₹10,641 Cr | - | |
Compare Revenue of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹56,234.0 Cr | 2.5% | -0.9% | 33.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 2.5% |
-0.9% |
33.3% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses